NCT04375358View on ClinicalTrials.gov

Creatinine Clearance as a Predictor of Successful Withdrawl of Continuous Renal Replacement Therapy in Intensive Care

CompletedOBSERVATIONAL
Enrollment

64

Participants

Timeline

Start Date

October 1, 2018

Primary Completion Date

March 30, 2021

Study Completion Date

March 30, 2021

Conditions
Dialysis WithdrawalCreatinine Clearance
Interventions
BIOLOGICAL

Blood and urine samples

To measure the clearance of creatinine, urea, potassium, magnesium, sodium, chlorine...

Trial Locations (1)

21000

Chu Dijon Bourgogne, Dijon

All Listed Sponsors
lead

Centre Hospitalier Universitaire Dijon

OTHER

NCT04375358 - Creatinine Clearance as a Predictor of Successful Withdrawl of Continuous Renal Replacement Therapy in Intensive Care | Biotech Hunter | Biotech Hunter